1. Home
  2. USGO vs EPRX Comparison

USGO vs EPRX Comparison

Compare USGO & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USGO
  • EPRX
  • Stock Information
  • Founded
  • USGO 2015
  • EPRX 2011
  • Country
  • USGO Canada
  • EPRX Canada
  • Employees
  • USGO N/A
  • EPRX N/A
  • Industry
  • USGO Precious Metals
  • EPRX
  • Sector
  • USGO Basic Materials
  • EPRX
  • Exchange
  • USGO Nasdaq
  • EPRX NYSE
  • Market Cap
  • USGO 130.7M
  • EPRX 113.6M
  • IPO Year
  • USGO 2023
  • EPRX N/A
  • Fundamental
  • Price
  • USGO $8.32
  • EPRX $2.99
  • Analyst Decision
  • USGO Strong Buy
  • EPRX Strong Buy
  • Analyst Count
  • USGO 1
  • EPRX 1
  • Target Price
  • USGO $24.00
  • EPRX $9.00
  • AVG Volume (30 Days)
  • USGO 54.4K
  • EPRX 12.2K
  • Earning Date
  • USGO 02-19-2025
  • EPRX 02-07-2025
  • Dividend Yield
  • USGO N/A
  • EPRX N/A
  • EPS Growth
  • USGO N/A
  • EPRX N/A
  • EPS
  • USGO N/A
  • EPRX N/A
  • Revenue
  • USGO N/A
  • EPRX N/A
  • Revenue This Year
  • USGO N/A
  • EPRX N/A
  • Revenue Next Year
  • USGO N/A
  • EPRX N/A
  • P/E Ratio
  • USGO N/A
  • EPRX N/A
  • Revenue Growth
  • USGO N/A
  • EPRX N/A
  • 52 Week Low
  • USGO $5.00
  • EPRX $2.20
  • 52 Week High
  • USGO $14.46
  • EPRX $4.08
  • Technical
  • Relative Strength Index (RSI)
  • USGO 35.62
  • EPRX N/A
  • Support Level
  • USGO $8.00
  • EPRX N/A
  • Resistance Level
  • USGO $11.40
  • EPRX N/A
  • Average True Range (ATR)
  • USGO 0.90
  • EPRX 0.00
  • MACD
  • USGO -0.40
  • EPRX 0.00
  • Stochastic Oscillator
  • USGO 6.40
  • EPRX 0.00

About USGO U.S. GoldMining Inc. Common stock

US Goldmining Inc is a mineral exploration and development company. It is focused on the exploration and development of a project located in Alaska, USA. The company's sole property is Whistler Project which is a gold-copper exploration project located in the Yentna Mining District, approximately 170 km northwest of Anchorage, Alaska.

About EPRX EUPRAXIA PHARMACEUTICALS INC

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.

Share on Social Networks: